Skip to main content
Clinical Trials/NL-OMON25032
NL-OMON25032
Completed
Not Applicable

A self regulatory weight reduction intervention in diabetes type II patients.

-0 sites270 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
-
Enrollment
270
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
-

Eligibility Criteria

Inclusion Criteria

  • Diabetes type II according to WHO classification (1999\): fasting blood glucose levels \> 126 mg/dl (7mmol/l) or levels \> 200 mg/dl (11\.1 mmol/l) two hours after an oral glucose tolerance test, treated by an internist from the Máxima Medical Centre, BMI 27\-45, between 21 and 70 years old, Caucasian patients who are able to understand, read and write in Dutch.

Exclusion Criteria

  • Patients with any severe co morbidity (except for cardiovascular diseases) will be excluded. Patients who are currently under treatment for a psychological or psychiatric disorder will also be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials